Levonorgestrel Patent Expiration
Levonorgestrel is Used for preventing pregnancy with the intrauterine system (IUS). It was first introduced by Population Council
Levonorgestrel Patents
Given below is the list of patents protecting Levonorgestrel, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Liletta | US11571328 | IUD insertion devices | Sep 07, 2040 | Medicines360 |
| Liletta | US10028858 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor | Mar 22, 2034 | Medicines360 |
| Liletta | US11090186 | Methods for using intrauterine systems and IUD insertion devices | Oct 24, 2033 | Medicines360 |
| Liletta | US12004992 | Kits for intrauterine systems and IUD insertion devices | Oct 06, 2033 | Medicines360 |
| Kyleena | US10987244 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Kyleena | US9668912 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Mirena | US10987244 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Mirena | US9668912 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Skyla | US10987244 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Skyla | US9668912 | Inserter | Apr 01, 2031 | Bayer Hlthcare |
| Kyleena | US10561524 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Kyleena | US9615965 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Mirena | US10561524 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Mirena | US9615965 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Skyla | US10561524 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Skyla | US9615965 | Inserter | Sep 16, 2029 | Bayer Hlthcare |
| Kyleena | US11850182 | Inserter | Sep 14, 2029 | Bayer Hlthcare |
| Mirena | US11850182 | Inserter | Sep 14, 2029 | Bayer Hlthcare |
| Skyla | US11850182 | Inserter | Sep 14, 2029 | Bayer Hlthcare |
| Kyleena | US11628088 | Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection | Feb 07, 2027 | Bayer Hlthcare |
| Skyla | US11628088 | Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection | Feb 07, 2027 | Bayer Hlthcare |
| Kyleena | US7252839 | Delivery system and a manufacturing process of a delivery system |
Nov 13, 2023
(Expired) | Bayer Hlthcare |
| Skyla | US7252839 | Delivery system and a manufacturing process of a delivery system |
Nov 13, 2023
(Expired) | Bayer Hlthcare |
| Mirena | US5785053 | Inserter for the positioning of an intrauterine device |
Dec 05, 2015
(Expired) | Bayer Hlthcare |
| Skyla | US5785053 | Inserter for the positioning of an intrauterine device |
Dec 05, 2015
(Expired) | Bayer Hlthcare |
Levonorgestrel's Family Patents
Explore Our Curated Drug Screens
Levonorgestrel Generic API Manufacturers
Several generic applications have been filed for Levonorgestrel. The first generic version for Levonorgestrel was by Watson Laboratories Inc and was approved on Jun 24, 2009. And the latest generic version is by Naari Pte Ltd and was approved on May 2, 2019.
Given below is the list of companies who have filed for Levonorgestrel generic, along with the locations of their manufacturing plants worldwide.
1. ALVOGEN
Alvogen Inc has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Discontinued | ORAL | N/A | Jun 5, 2015 |
Manufacturing Plant Locations New
Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Levonorgestrel. This 1.5mg version comes by the name ATHENTIA NEXT. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Dec 8, 2015 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
3. FDN CONSUMER
Foundation Consumer Healthcare Llc has filed for 2 different strengths of generic version for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Fdn Consumer.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Discontinued | ORAL | N/A | Aug 28, 2009 |
| 1.5MG | tablet | Discontinued | ORAL | N/A | Jul 12, 2012 |
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Mar 25, 2016 |
5. L PERRIGO CO
L Perrigo Co has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by L Perrigo Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Dec 30, 2010 |
6. LABORATOIRE HRA
Laboratoire Hra Pharma has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Laboratoire Hra.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Jul 3, 2018 |
Manufacturing Plant Locations New
Laboratoire Hra's manufacturing plants are situated in 1 country - France. Given below are the details of these plant locations as well as the firm names of Laboratoire Hra as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| France |
| |||
7. LOTUS PHARM CO LTD
Lotus Pharmaceutical Co Ltd Nantou Plant has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Lotus Pharm Co Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Sep 2, 2016 |
8. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Levonorgestrel. Out of these 1.5mg version comes by the name FALLBACK SOLO. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Jan 23, 2013 |
| 1.5MG | tablet | Over the counter | ORAL | N/A | Jun 19, 2014 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
9. NAARI PTE LTD
Naari Pte Ltd has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Naari Pte Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | May 2, 2019 |
10. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Levonorgestrel. This 1.5mg version comes by the name HER STYLE. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Mar 11, 2016 |
11. NOVEL LABS INC
Novel Laboratories Inc has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Feb 22, 2013 |
12. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Aug 20, 2014 |
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Levonorgestrel. This 1.5mg version comes by the name OPCICON ONE-STEP. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Sep 11, 2014 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
14. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75MG | tablet | Discontinued | ORAL | N/A | Jun 24, 2009 |
15. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Jul 12, 2012 |
16. XIROMED
Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Levonorgestrel. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5MG | tablet | Over the counter | ORAL | N/A | Sep 18, 2018 |
| 0.75MG | tablet | Discontinued | ORAL | N/A | Sep 2, 2016 |
Manufacturing Plant Locations New
Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||